Table 4:
ER-positive N = 205 | ER-negative N = 193 | ER-negative/ER-positive | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Controls | ER-positive | ER-negative | OR | 95% CI | p-trend | OR | 95% CI | p-trend | p-het | |||
Age at menarche (years) | ||||||||||||
<15 | 177 | 51 | 39 | 1·00 | 1·00 | |||||||
15 | 225 | 50 | 46 | 0·69 | 0·43 | 0·85 | 0·85 | 0·51 | 1·39 | 0·60 | ||
16 | 145 | 37 | 27 | 0·73 | 0·43 | 0·69 | 0·69 | 0·39 | 1·22 | 0·84 | ||
≥17 | 146 | 42 | 43 | 0·84 | 0·50 | 1·13 | 0·74 | 1·13 | 0·67 | 1·92 | 0·77 | 0·36 |
Parity | ||||||||||||
Nulliparous | 19 | 12 | 14 | 1·00 | 1·00 | |||||||
1–2 | 127 | 48 | 36 | 0·82 | 0·31 | 2·16 | 0·34 | 0·13 | 0·88 | 0·13 | ||
3–4 | 256 | 72 | 53 | 0·58 | 0·23 | 1·49 | 0·23 | 0·09 | 0·57 | 0·83 | ||
≥5 | 406 | 76 | 91 | 0·49 | 0·19 | 1·26 | 0·24 | 0·28 | 0·11 | 0·70 | 0·004 | 0·33 |
Age at first birth (years) | ||||||||||||
<19 | 245 | 46 | 50 | 1·00 | 1·00 | |||||||
19–21 | 220 | 49 | 56 | 1·10 | 0·67 | 1·78 | 1·26 | 0·80 | 2·00 | 0·55 | ||
22–25 | 165 | 48 | 42 | 1·10 | 0·66 | 1·83 | 1·06 | 0·64 | 1·75 | 1·00 | ||
≥26 | 118 | 32 | 24 | 1·09 | 0·61 | 1·93 | 0·72 | 1·02 | 0·57 | 1·84 | 0·95 | 0·84 |
Median months breastfeeding per pregnancy (among parous women) | ||||||||||||
<13 | 163 | 68 | 42 | 1·00 | 1·00 | |||||||
13–18 | 276 | 54 | 53 | 0·61 | 0·39 | 0·95 | 0·81 | 0·50 | 1·30 | 0·35 | ||
≥19 | 313 | 51 | 66 | 0·54 | 0·34 | 0·85 | 0·01 | 0·89 | 0·56 | 1·42 | 0·82 | 0·07 |
Polytomous logistic regression models were adjusted for age, education, study site, body size, family history of breast cancer, menopausal status, age at menopause, and all reproductive factors listed above. P-values <0·05 were considered statistically significant. ER=oestrogen receptor. OR=odds ratio. CI=confidence index. P-het=p-heterogeneity test.